Assaf, C. “Zanolimumab (HuMax-CD4®), a Fully Human Monoclonal Antibody in Clinical Development for Cutaneous T-Cell Lymphoma”. Hematology Meeting Reports (formerly Haematologica Reports) 2, no. 5 (June 23, 2009). Accessed July 22, 2024. https://www.pagepress.org/journals/hmr/article/view/736.